• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Plasma heat shock protein 27 is associated with coronary artery disease, abdominal aortic aneurysm and peripheral artery disease.血浆热休克蛋白27与冠状动脉疾病、腹主动脉瘤和外周动脉疾病相关。
Springerplus. 2014 Oct 28;3:635. doi: 10.1186/2193-1801-3-635. eCollection 2014.
2
Serum heat shock protein 27 levels represent a potential therapeutic target for atherosclerosis: observations from a human cohort and treatment of female mice.血清热休克蛋白 27 水平代表动脉粥样硬化的潜在治疗靶点:来自人类队列的观察结果和对雌性小鼠的治疗。
J Am Coll Cardiol. 2013 Oct 15;62(16):1446-54. doi: 10.1016/j.jacc.2013.05.041. Epub 2013 Jun 10.
3
Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome.热休克蛋白27在人类动脉粥样硬化斑块中的表达及急性冠状动脉综合征患者血浆热休克蛋白27水平升高
Circulation. 2006 Aug 29;114(9):886-93. doi: 10.1161/CIRCULATIONAHA.105.541219. Epub 2006 Aug 21.
4
HSP27 expression in the human peripheral blood mononuclear cells as an early prognostic biomarker in coronary artery disease patients.热休克蛋白27(HSP27)在人类外周血单核细胞中的表达作为冠心病患者的早期预后生物标志物
Diabetes Metab Syndr. 2019 May-Jun;13(3):1791-1795. doi: 10.1016/j.dsx.2019.04.010. Epub 2019 Apr 14.
5
Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis.通过差异蛋白质组学方法鉴定热休克蛋白27作为动脉粥样硬化的潜在标志物。
Circulation. 2004 Oct 12;110(15):2216-9. doi: 10.1161/01.CIR.0000136814.87170.B1. Epub 2004 Jul 12.
6
Circulating levels of Hsp27 in microvascular complications of diabetes: Prospects as a biomarker of diabetic nephropathy.循环 Hsp27 水平与糖尿病微血管并发症:作为糖尿病肾病生物标志物的前景。
J Diabetes Complications. 2018 Feb;32(2):221-225. doi: 10.1016/j.jdiacomp.2017.10.004. Epub 2017 Oct 16.
7
Association of chronic obstructive pulmonary, coronary artery, or peripheral artery disease with abdominal aortic aneurysm rupture.慢性阻塞性肺疾病、冠状动脉疾病或外周动脉疾病与腹主动脉瘤破裂的关联。
Int Angiol. 2017 Aug;36(4):322-331. doi: 10.23736/S0392-9590.16.03762-7. Epub 2016 Sep 8.
8
D-Dimer Is a Diagnostic Biomarker of Abdominal Aortic Aneurysm in Patients With Peripheral Artery Disease.D-二聚体是外周动脉疾病患者腹主动脉瘤的诊断生物标志物。
Front Cardiovasc Med. 2022 Jun 3;9:890228. doi: 10.3389/fcvm.2022.890228. eCollection 2022.
9
The role of novel cytokines in inflammation: Defining peripheral artery disease among patients with coronary artery disease.新型细胞因子在炎症中的作用:在冠心病患者中定义外周动脉疾病。
Vasc Med. 2018 Oct;23(5):428-436. doi: 10.1177/1358863X18763096. Epub 2018 Apr 11.
10
[Atheromatous extra-coronary injury in patients with coronary disease: Result of a cross-sectional centre study carried out in the east of Algeria].[冠心病患者的动脉粥样硬化性冠状动脉外损伤:在阿尔及利亚东部开展的一项横断面中心研究结果]
Ann Cardiol Angeiol (Paris). 2019 Oct;68(4):201-206. doi: 10.1016/j.ancard.2019.01.001. Epub 2019 Mar 8.

引用本文的文献

1
Unveiling the role of exercise in modulating plasma heat shock protein 27 levels: insights for exercise immunology and cardiovascular health.揭示运动在调节血浆热休克蛋白27水平中的作用:对运动免疫学和心血管健康的见解。
Mol Cell Biochem. 2025 Mar;480(3):1381-1401. doi: 10.1007/s11010-024-05089-8. Epub 2024 Aug 22.
2
Fractional heat shock protein 27 urine excretion as a short-term predictor in acute exacerbation of chronic obstructive pulmonary disease.分数热休克蛋白27尿排泄作为慢性阻塞性肺疾病急性加重的短期预测指标
Ann Transl Med. 2021 Jan;9(2):117. doi: 10.21037/atm-20-3683.
3
Role of Heat Shock Protein 27 in Modulating Atherosclerotic Inflammation.热休克蛋白 27 在调节动脉粥样硬化炎症中的作用。
J Cardiovasc Transl Res. 2021 Feb;14(1):3-12. doi: 10.1007/s12265-020-10000-z. Epub 2020 Jul 13.
4
Circulating heat shock protein 27 as a novel marker of subclinical atherosclerosis in type 2 diabetes: a cross-sectional community-based study.循环热休克蛋白 27 作为 2 型糖尿病亚临床动脉粥样硬化的新型标志物:一项基于社区的横断面研究。
BMC Cardiovasc Disord. 2020 Apr 25;20(1):198. doi: 10.1186/s12872-020-01456-7.
5
Heat shock protein 27 as a predictor of prognosis in patients admitted to hospital with acute COPD exacerbation.热休克蛋白 27 作为急性 COPD 加重住院患者预后预测因子。
Cell Stress Chaperones. 2020 Jan;25(1):141-149. doi: 10.1007/s12192-019-01057-0. Epub 2019 Dec 9.
6
Role of heat shock protein and cytokine expression as markers of clinical outcomes with glutamine-supplemented parenteral nutrition in surgical ICU patients.热休克蛋白和细胞因子表达在外科 ICU 患者中作为谷氨酰胺补充肠外营养临床结局的标志物的作用。
Clin Nutr. 2020 Feb;39(2):563-573. doi: 10.1016/j.clnu.2019.02.045. Epub 2019 Mar 13.
7
Prophylactic salpingo-oophorectomy & surgical menopause for inherited risks of cancer: the need to identify biomarkers to assess the theoretical risk of premature coronary artery disease.预防性输卵管卵巢切除术及手术绝经以降低遗传性癌症风险:识别生物标志物以评估早发性冠状动脉疾病理论风险的必要性。
Womens Midlife Health. 2018 Apr 27;4:7. doi: 10.1186/s40695-018-0037-y. eCollection 2018.
8
Serum heat shock protein 27 levels predict cardiac mortality in hemodialysis patients.血清热休克蛋白 27 水平可预测血液透析患者的心脏死亡率。
BMC Nephrol. 2018 Dec 17;19(1):359. doi: 10.1186/s12882-018-1157-1.
9
Heat Shock Proteins in Vascular Diabetic Complications: Review and Future Perspective.热休克蛋白在血管糖尿病并发症中的作用:综述与展望。
Int J Mol Sci. 2017 Dec 14;18(12):2709. doi: 10.3390/ijms18122709.
10
Extracellular Release and Signaling by Heat Shock Protein 27: Role in Modifying Vascular Inflammation.热休克蛋白27的细胞外释放与信号传导:在调节血管炎症中的作用
Front Immunol. 2016 Jul 26;7:285. doi: 10.3389/fimmu.2016.00285. eCollection 2016.

本文引用的文献

1
Hsp27 as a therapeutic target in cancers.热休克蛋白 27 作为癌症治疗靶点。
Curr Drug Targets. 2014 Apr;15(4):423-31. doi: 10.2174/13894501113146660230.
2
Heat shock protein-27 attenuates foam cell formation and atherogenesis by down-regulating scavenger receptor-A expression via NF-κB signaling.热休克蛋白-27通过核因子κB信号通路下调清道夫受体-A的表达,从而减轻泡沫细胞形成和动脉粥样硬化。
Biochim Biophys Acta. 2013 Dec;1831(12):1721-8. doi: 10.1016/j.bbalip.2013.07.015. Epub 2013 Aug 11.
3
Serum heat shock protein 27 levels represent a potential therapeutic target for atherosclerosis: observations from a human cohort and treatment of female mice.血清热休克蛋白 27 水平代表动脉粥样硬化的潜在治疗靶点:来自人类队列的观察结果和对雌性小鼠的治疗。
J Am Coll Cardiol. 2013 Oct 15;62(16):1446-54. doi: 10.1016/j.jacc.2013.05.041. Epub 2013 Jun 10.
4
A sequence variant associated with sortilin-1 (SORT1) on 1p13.3 is independently associated with abdominal aortic aneurysm.一个与 1p13.3 上的 sortilin-1(SORT1)相关的序列变异与腹主动脉瘤独立相关。
Hum Mol Genet. 2013 Jul 15;22(14):2941-7. doi: 10.1093/hmg/ddt141. Epub 2013 Mar 27.
5
Chronic over-expression of heat shock protein 27 attenuates atherogenesis and enhances plaque remodeling: a combined histological and mechanical assessment of aortic lesions.慢性过表达热休克蛋白 27 可减轻动脉粥样硬化形成并增强斑块重构:对主动脉病变的组织学和力学综合评估。
PLoS One. 2013;8(2):e55867. doi: 10.1371/journal.pone.0055867. Epub 2013 Feb 7.
6
Extracellular HSP27 acts as a signaling molecule to activate NF-κB in macrophages.细胞外 HSP27 作为信号分子在巨噬细胞中激活 NF-κB。
Cell Stress Chaperones. 2013 Jan;18(1):53-63. doi: 10.1007/s12192-012-0356-0. Epub 2012 Aug 1.
7
Small heat shock proteins in redox metabolism: implications for cardiovascular diseases.小分子热休克蛋白在氧化还原代谢中的作用:对心血管疾病的影响。
Int J Biochem Cell Biol. 2012 Oct;44(10):1632-45. doi: 10.1016/j.biocel.2012.06.006. Epub 2012 Jun 15.
8
Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target.热休克蛋白27(HSP27):疾病生物标志物与治疗靶点。
Fibrogenesis Tissue Repair. 2012 May 7;5(1):7. doi: 10.1186/1755-1536-5-7.
9
Prevalence of risk factors and of coronary artery disease, ischemic stroke, carotid arterial disease and lower extremity peripheral arterial disease in 96 patients undergoing elective surgery for an abdominal aortic aneurysm.96例接受腹主动脉瘤择期手术患者的危险因素及冠状动脉疾病、缺血性卒中、颈动脉疾病和下肢外周动脉疾病的患病率。
Int J Angiol. 2008 Fall;17(3):141-2. doi: 10.1055/s-0031-1278298.
10
Proteotoxic stress and circulating cell stress proteins in the cardiovascular diseases.蛋白毒性应激和心血管疾病中的循环细胞应激蛋白。
Cell Stress Chaperones. 2012 May;17(3):303-11. doi: 10.1007/s12192-011-0318-y. Epub 2012 Jan 5.

血浆热休克蛋白27与冠状动脉疾病、腹主动脉瘤和外周动脉疾病相关。

Plasma heat shock protein 27 is associated with coronary artery disease, abdominal aortic aneurysm and peripheral artery disease.

作者信息

Jin Cao, Phillips Victoria L, Williams Michael Ja, van Rij Andre M, Jones Gregory T

机构信息

Department of Surgery, University of Otago, PO Box 913, Dunedin, New Zealand.

Department of Medicine, University of Otago, PO Box 913, Dunedin, New Zealand.

出版信息

Springerplus. 2014 Oct 28;3:635. doi: 10.1186/2193-1801-3-635. eCollection 2014.

DOI:10.1186/2193-1801-3-635
PMID:25392804
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4218927/
Abstract

Low protein levels of Hsp27 have been reported in atherosclerotic plaques. In addition, human studies have indicated that circulating Hsp27 levels are lower in coronary artery disease patients compared with controls. It remains, however, unclear whether this applies to other forms of atherosclerotic disease. Plasma Hsp27 from 280 subjects was examined by ELISA. The cohort included 80 coronary artery disease (CAD), 40 peripheral artery disease (PAD) and 80 abdominal aortic aneurysm (AAA) patients. Eighty elderly subjects, without any clinical history of vascular diseases, were used as a control group. Receiver operating curve (ROC) and logistic regression model analysis were performed to evaluate the potential value of Hsp27 as a circulating biomarker. Patients with atherosclerotic vascular diseases had significantly lower levels of Hsp27 than control subjects (p < 0.001). Moreover, Hsp27 was significantly lower in CAD patients than other atherosclerotic vascular disease groups (p < 0.001). There was no difference in Hsp27 levels between the AAA and PAD groups. Using the ROC-generated optimal cut-off values for Hsp27, logistic regression modeling indicated that low plasma Hsp27 was independently associated with the presence of multiple forms of atherosclerotic disease. In conclusion, circulating Hsp27 is significantly lower in patients with multiple forms of atherosclerotic arterial disease.

摘要

已有报道称动脉粥样硬化斑块中热休克蛋白27(Hsp27)的蛋白水平较低。此外,人体研究表明,与对照组相比,冠状动脉疾病患者的循环Hsp27水平较低。然而,这是否适用于其他形式的动脉粥样硬化疾病仍不清楚。通过酶联免疫吸附测定(ELISA)检测了280名受试者的血浆Hsp27。该队列包括80名冠状动脉疾病(CAD)患者、40名外周动脉疾病(PAD)患者和80名腹主动脉瘤(AAA)患者。80名无任何血管疾病临床病史的老年受试者作为对照组。进行了受试者工作特征曲线(ROC)和逻辑回归模型分析,以评估Hsp27作为循环生物标志物的潜在价值。动脉粥样硬化血管疾病患者的Hsp27水平显著低于对照组(p < 0.001)。此外,CAD患者的Hsp27水平显著低于其他动脉粥样硬化血管疾病组(p < 0.001)。AAA组和PAD组之间的Hsp27水平没有差异。使用ROC生成的Hsp27最佳临界值,逻辑回归模型表明低血浆Hsp27与多种形式的动脉粥样硬化疾病独立相关。总之,多种形式的动脉粥样硬化性动脉疾病患者的循环Hsp27水平显著较低。